Epidemiology, diagnosis and management of intracranial atherosclerotic disease

References

• Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke26, 14–20 (1995).
   PubMed Web of Science ®Google Scholar
• Sacco RL, Adams R, Albers G et al.; American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke37, 577–617 (2006).
   PubMed Web of Science ®Google Scholar
• Kuller L, Resiler DM. An explanation for variations in distribution of stroke and arteriosclerotic heart disease among populations and racial groups. Am. J. Epidemiol.93, 1–9 (1971).
   PubMed Web of Science ®Google Scholar
• Feldmann E, Daneault N, Kwan E et al. Chinese–white differences in the distribution of occlusive cerebrovascular disease. Neurology40, 1541–1545 (1990).
   PubMed Web of Science ®Google Scholar
• Fields WS, Lemak NA. Joint study of extracranial arterial occlusion. X. Internal carotid artery occlusion. JAMA235, 2734–2738 (1976).
   PubMedGoogle Scholar
• Gorelick PB, Han J, Huang Y, Wong KS. Epidemiology. In: Intracranial Atherosclerosis. Kim JS, Caplan LR, Wong KS (Eds). Wiley-Blackwell, NJ, USA, 33–44 (2008).
   Google Scholar
• Suri MFK, Johnston SC. Epidemiology of intracranial stenosis. J. Neuroimaging19, 11S–16S (2009).
   PubMed Web of Science ®Google Scholar
• Gorelick PB, Caplan LR, Hier DB, Parker SL, Patel D. Racial differences in the distribution of anterior circulation occlusive disease. Neurology34, 54–59 (1984).
   PubMed Web of Science ®Google Scholar
• Gorelick PB, Caplan LR, Hier DB, Parker SL, Patel D. Racial differences in the distribution of posterior circulation occlusive disease. Stroke16, 785–790 (1985).
   PubMed Web of Science ®Google Scholar
• White H, Boden-Albala B, Wang C et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation111, 1327–1331 (2005).
   PubMed Web of Science ®Google Scholar
• Markus HS, Khan U, Birns J et al. Differences in stroke subtypes between black and white patients with stroke. The South London Ethnicity and Stroke Study. Circulation116, 2157–2164 (2007).
   PubMed Web of Science ®Google Scholar
• Weimer C, Goertler M, Harms L, Diener HC; for the German Stroke Study Collaboration. Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia. Arch. Neurol.63, 1287–1291 (2006).
   PubMedGoogle Scholar
• Weber R, Kraywinkel K, Diener HC, Weimer C; on behalf of the German Stroke Study Collaboration. Symptomatic intracranial atherosclerotic stenoses: prevalence and prognosis in patients with acute cerebral ischemia. Cerebrovasc. Dis.30, 188–193 (2010).
   PubMedGoogle Scholar
• Kim JT, Yoo SH, Kwon JH, Kwon SU, Kim JS. Subtyping of ischemic stroke based on vascular imaging: analysis of 1167 acute, consecutive patients. J. Clin. Neurol.2, 225–230 (2006).
   PubMedGoogle Scholar
• Takahashi K, Kitani M, Fukuda H, Kobayashi S. Vascular risk factors for atherosclerotic lesions of the middle cerebral artery detected by magnetic resonance angiography (MRA). Acta Neurol. Scand.100, 395–399 (1999).
   PubMedGoogle Scholar
• Liu HM, Tu YK, Yip PK, Su CT. Evaluation of intracranial and extracranial carotid steno-occlusive diseases in Taiwan Chinese patients with MR angiography: preliminary experiences. Stroke27, 650–653 (1996).
   PubMed Web of Science ®Google Scholar
• Huang YN, Gao S, Li SW et al. Vascular lesions in Chinese patients with transient ischemic attacks. Neurology48, 524–525 (1997).
   PubMed Web of Science ®Google Scholar
• Wong KS, Li H, Chan YL et al. Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke31, 2641–2647 (2000).
   PubMed Web of Science ®Google Scholar
• Suwanwela NC, Chutinetr A. Risk factors for atherosclerosis of cervicocerebral arteries: intracranial versus extracranial. Neuroepidemiology22, 37–40 (2003).
   PubMed Web of Science ®Google Scholar
• De Silva DA, Woon FP, Lee MP et al. South Asia patients with ischemic stroke. Intracranial large arteries are the predominant site of disease. Stroke38, 2592–2594 (2007).
   PubMed Web of Science ®Google Scholar
• Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke39, 2396–2399 (2008).
   PubMed Web of Science ®Google Scholar
• Wong KS. Global burden of intracranial atherosclerosis. Int. J. Stroke1, 158–159 (2006).
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Feldmann E, Gomez CR et al. Intracranial atherosclerotic disease: an update. Ann. Neurol.66, 730–738 (2009).
   PubMed Web of Science ®Google Scholar
• Mazighi M, Labreuche J, Gongora-Rivera F, Duyckaerts C, Hauw JJ, Amarenco P. Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke39, 1142–1147 (2008).
   PubMedGoogle Scholar
• Swartz RH, Bhuta SS, Farb RI et al. Intracranial arterial wall imaging using high-resolution 3-Tesla contrast-enhanced MRI. Neurology17, 627–634 (2009).
   Google Scholar
• Uehara T, Tabuchi M, Mori E. Risk factors for occlusive lesions of intracranial arteries in stroke-free Japanese. Eur. J. Neurol.12, 218–222 (2005).
   PubMedGoogle Scholar
• Park KY, Chung CS, Lee KH et al. Prevalence and risk factors of intracranial atherosclerosis in an asymptomatic Korean population. J. Clin. Neurol.2, 29–33 (2006).
   PubMedGoogle Scholar
• Wong KS, Huang YN, Yang HB et al. A door-to-door survey of intracranial atherosclerosis in Liangbei County, China. Neurology68, 2031–2034 (2007).
   PubMed Web of Science ®Google Scholar
• Wong KS, Ng PW, Tang A, Liu R, Yeung V, Tomlinson B. Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology68, 2035–2038 (2007).
   PubMed Web of Science ®Google Scholar
• Huang HW, Guo MH, Lin RJ et al. Prevalence and risk factors of middle cerebral artery stenosis in asymptomatic residents in Rongqi County, Guangdong. Cerebrovasc. Dis.24, 111–115 (2007).
   PubMed Web of Science ®Google Scholar
• Elmore EM, Mosquera A, Weinberger J. The prevalence of asymptomatic intracranial large-vessel occlusive disease: the role of diabetes. J. Neuroimaging13, 224–227 (2003).
   PubMedGoogle Scholar
• Nahab F, Cotsonis G, Lynn M et al. Prevalence and prognosis of coexistent asymptomatic intracranial stenosis. Stroke39, 1039–1041 (2008).
   PubMedGoogle Scholar
• Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke17, 648–655 (1986).
   PubMed Web of Science ®Google Scholar
• Initari D, Hachinski VC, Wayne TD, Barnett HJM. Racial differences in the anterior circulation in cerebrovascular disease: how much can be explained by risk factor? Arch. Neurol.47, 1080–1084 (1990).
   PubMedGoogle Scholar
• Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke27, 1974–1980 (1996).
   PubMed Web of Science ®Google Scholar
• Bae HJ, Lee J, Park JM et al. Risk factors of intracranial cerebral atherosclerosis among asymptomatics. Cerebrovasc. Dis.24, 355–360 (2007).
   PubMed Web of Science ®Google Scholar
• Park JH, Kwon HM, Roh JK. Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis. Eur. J. Neurol.14, 379–386 (2007).
   PubMed Web of Science ®Google Scholar
• Bang OY, Kim JW, Lee JH et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology65, 295–298 (2005).
   Google Scholar
• Lee SJ, Cho SJ, Moon HS et al. Combined extracranial and intracranial atherosclerosis in Korean patients. Arch. Neurol.60, 1561–1564 (2003).
   PubMedGoogle Scholar
• Leung SY, Ng THK, Yuen ST, Lauder IJ, Ho FCS. Pattern of cerebral atherosclerosis in Hong Kong Chinese: severity in intracranial and extracranial vessels. Stroke24, 779–786 (1993).
   PubMedGoogle Scholar
• Arenillas JF, Molina CA, Chacon P et al. High lipoprotein(a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology63, 27–32 (2004).
   PubMed Web of Science ®Google Scholar
• Yasaka M, Yamaguchi T, Shichiri M. Distribution of atherosclerosis and risk factors in atherothrombotic occlusion. Stroke24, 206–211 (1993).
   PubMed Web of Science ®Google Scholar
• Moossy J. Pathology of cerebral atherosclerosis. Influence of age, race, and gender. Stroke24, I22–23, I31–32 (1993).
   Google Scholar
• Obviagele B, Saver JL, Lynn MJ, Chimowitz M; for the WASID Study Group. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherosclerosis. Neurology66, 1344–1349 (2006).
   PubMedGoogle Scholar
• Rincon F, Sacco RL, Kranwinkel et al. Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc. Dis.28, 65–71 (2009).
   PubMed Web of Science ®Google Scholar
• Chimowitz MI, Lynn MJ, Howlett-Smith H et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N. Engl. J. Med.352, 1305–1316 (2005).
   PubMed Web of Science ®Google Scholar
• Obviagele B, Cruz-Flores S, Lynn MJ, Chimowitz MI, for the Warfarin–Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch. Neurol.65, 733–737 (2008).
   PubMedGoogle Scholar
• Mazighi M, Tanasescu R, Ducrocq X et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology66, 1187–1191 (2006).
   PubMed Web of Science ®Google Scholar
• Kasner SE, Chimowitz MI, Lynn MJ et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation13, 555–563 (2006).
   Google Scholar
• Chaturvedi S, Turan TN, Lynn MJ et al. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology69, 2063–2068 (2007).
   PubMed Web of Science ®Google Scholar
• Williams JE, Chimowitz MI, Cotsonis GA, Lynn MJ, Waddy SP; for the WASID Investigators. Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke38, 2055–2062 (2007).
   PubMedGoogle Scholar
• Rundek T. Do women have worse outcome after stroke caused by intracranial arterial stenosis? Stroke38, 2025–2027 (2007).
   PubMedGoogle Scholar
• Feldmann E. Diagnosis and quantitation of intracranial stenosis. J. Neuroimaging19, 22S–24S (2009).
   PubMed Web of Science ®Google Scholar
• Kaufmann TJ, Huston J, Mandrekar JN, Schleck CD, Thielen KR, Kallmes DF. Complications of diagnostic cerebral angiography: evaluation of 19,826 consecutive patients. Radiology243, 812–819 (2007).
   PubMed Web of Science ®Google Scholar
• Feldmann E, Wilterdink JL, Kosinski A et al. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology68, 2099–2106 (2007).
   PubMed Web of Science ®Google Scholar
• Krejza J, Mariak Z, Babikian VL. Importance of angle correction in the measurement of blood flow velocity with transcranial Doppler sonography. AJNR Am. J. Neuroradiol.22, 1743–1747 (2001).
   PubMedGoogle Scholar
• Baumgartner RW, Mattle HP, Schroth G. Assessment of ≥50% and <50% Intracranial stenoses by transcranial color-coded duplex sonography. Stroke30, 87–92 (1999).
   PubMed Web of Science ®Google Scholar
• Arenillas JF, Molina CA, Montaner J et al. Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study. Stroke32, 2898–2904 (2001).
   PubMed Web of Science ®Google Scholar
• Wong KS, Li H, Lam WW, Chan YL, Kay R. Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke. Stroke33, 532–536 (2002).
   PubMed Web of Science ®Google Scholar
• Arenillas JF, Alvarez-Sabín J, Molina CA et al. Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis. Stroke39, 1456–1463 (2008).
   PubMed Web of Science ®Google Scholar
• Turan TN, Bonilha L, Morgan PS, Adams RJ, Chimowitz MI. Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J. Neuroimaging DOI: 10.1111/j.1552-6569.2009.00442.x (2009) (Epub ahead of print).
   Google Scholar
• Meyers PM, Schumacher HC, Gray WA et al. Intravascular ultrasound of symptomatic intracranial stenosis demonstrates atherosclerotic plaque with intraplaque hemorrhage: a case report. J. Neuroimaging19, 266–270 (2009).
   PubMed Web of Science ®Google Scholar
• Turan TN, Cotsonis G, Lynn MJ, Chaturvedi S, Chimowitz M; Warfarin–Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation115, 2969–2975 (2007).
   PubMed Web of Science ®Google Scholar
• Kwon SU, Cho YJ, Koo JS et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke36, 782–786 (2005).
   PubMed Web of Science ®Google Scholar
• Gao S, Wong KS, Hansberg T, Lam WW, Droste DW, Ringelstein EB. Microembolic signal predicts recurrent cerebral ischemic events in acute stroke patients with middle cerebral artery stenosis. Stroke35, 2832–2836 (2004).
   PubMed Web of Science ®Google Scholar
• Wong KS, Chen C, Fu J et al.; CLAIR study investigators. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol.9, 489–497 (2010).
   PubMed Web of Science ®Google Scholar
• Turan TN, Maidan L, Cotsonis et al. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke40, 505–509 (2009).
   PubMed Web of Science ®Google Scholar
• The EC–IC Bypass study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N. Engl. J. Med.313, 1191–1200 (1985).
   PubMed Web of Science ®Google Scholar
• Amin-Hanjani S, Charbel FT. Is extracranial–intracranial arterial bypass surgery effective in certain patients? Neurol. Clin.24, 729–743 (2006).
   PubMedGoogle Scholar
• Barnett HJM. Hemodynamic cerebral ischemia. An appeal for systematic data gathering prior to a new EC/IC trial. Stroke28, 1857–1860 (1997).
   PubMed Web of Science ®Google Scholar
• Grubb RL Jr, Powers WJ, Derdeyn CP, Adams HP, Clarke WR. The Carotid Occlusion Surgery Study. Neurosurg. Focus14, e9 (2003).
   Google Scholar
• Ogasawara K, Ogawa A. Japanese EC–IC Bypass Trial (JET study). Nippon. Rinsho.64, 524–527 (2006).
   PubMedGoogle Scholar
• Sundt TM, Smith HC, Campbell JK, Vietstra RE, Gucchiara RF, Stanson AW. Transluminal angioplasty for basilar artery stenosis. Mayo Clin. Proc.55, 673–680 (1980).
   PubMed Web of Science ®Google Scholar
• Siddiq F, Vazquez G, Memon MZ et al. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases. A multicenter study. Stroke39, 2505–2510 (2008).
   PubMedGoogle Scholar
• Marks MP, Wojak JC, Al-Ali F et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke37, 1016–1020 (2006).
   PubMed Web of Science ®Google Scholar
• Siddiq F, Memon MZ, Vazquez G, Safdar A, Qureshi AI. Comparison between primary angioplasty and stent placement for symptomatic intracranial atherosclerotic disease: meta-analysis of case series. Neurosurgery65, 1024–1033 (2009).
   PubMedGoogle Scholar
• The SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke35, 1388–1392 (2004).
   PubMed Web of Science ®Google Scholar
• Bose A, Hartmann M, Henkes H et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke38, 1531–1537 (2007).
   PubMed Web of Science ®Google Scholar
• Fiorella D, Levy EI, Turk AS et al. US multi-center experience with the Wingspan Stent System for the treatment of intracranial atheromatous disease: periprocedural results. Stroke38, 881–887 (2007).
   PubMed Web of Science ®Google Scholar
• Levy EI, Turk AS, Albuquerque FC et al. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery61, 644–650 (2007).
   PubMed Web of Science ®Google Scholar
• Samaniego EA, Hetzel S, Thirunarayanan S, Aagaard-Kienitz B, Turk AS, Levine R. Outcome of symptomatic intracranial atherosclerotic disease. Stroke40, 2983–2987 (2009).
   PubMedGoogle Scholar
• Gröschel K, Schnaudigel S, Pilgram SM, Wasser K, Kastrup A. A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke40, e340–e347 (2009).
   Google Scholar
• Qureshi AI, Hussein HM, El-Gengaihy A, Abdelmoula M, Suri MF. Concurrent comparison of outcomes of primary angioplasty and of stent placement in high-risk patients with symptomatic intracranial stenosis. Neurosurgery62, 1053–1060 (2008).
   PubMedGoogle Scholar
• Moskowitz SI, Kelly ME, Obuchowski N, Fiorella D. Impact of WASID and Wingspan on the frequency of intracranial angioplasty and stenting at a high volume tertiary care hospital. J. Neurointervent. Surg.1, 165–167 (2009).
   PubMedGoogle Scholar
• Lylyk P, Vila JF, Miranda C et al. Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol. Res.27(Suppl. 1), S84–S88 (2005).
   Web of Science ®Google Scholar
• Fiorella D, Chow MM, Anderson M, Woo H, Rasmussen PA, Masaryk TJ. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery61, 236–242 (2007).
   PubMedGoogle Scholar
• Jiang WJ, Xu XT, Du B et al. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology68, 420–426 (2007).
   PubMedGoogle Scholar
• Suh DC, Kim JK, Choi JW et al. Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. Am. J. Neuroradiol.29, 781–785 (2008).
   PubMed Web of Science ®Google Scholar
• Zaidat OO, Klucznik R, Alexander MJ et al. The NIH registry on use of the Wingspan stent for symptomatic 70–99% intracranial arterial stenosis. Neurology70, 1518–1524 (2008).
   PubMed Web of Science ®Google Scholar
• Miao ZR, Feng L, Li S et al. Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: long-term follow-up at a single center. Neurosurgery64, 79–84 (2009).
   PubMedGoogle Scholar
• Wolfe TJ, Fitzsimmons BF, Hussain SI, Lynch JR, Zaidat OO. Long term clinical and angiographic outcomes with the Wingspan stent for treatment of symptomatic 50–99% intracranial atherosclerosis: single center experience in 51 cases. J. Neurointervent. Surg.1, 40–43 (2009).
   PubMed Web of Science ®Google Scholar
• Nahab F, Lynn MJ, Kasner SE et al. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology72, 2014–2019 (2009).
   PubMed Web of Science ®Google Scholar
• Kurre W, Berkefeld J, Brassel F et al. In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses: results from the INTRASTENT multicentric registry. Stroke41, 494–498 (2010).
   PubMedGoogle Scholar
• Lutsep HL. Symptomatic intracranial stenosis: best medical treatment vs. intracranial stenting. Curr. Opin. Neurol.22, 69–74 (2009).
   PubMed Web of Science ®Google Scholar